Search Within

Francisco Sanchez Vega

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (60)
  2. Meeting Abstract (29)
  3. Editorial (1)
  4. Review (1)
Groups
  1. Computational Oncology Service (91)
  2. Epidemiology and Biostatistics (91)
  3. GSK Faculty (91)
  4. Human Oncology and Pathogenesis Program (91)
  5. Sloan Kettering Institute Postdocs (91)
  6. Surgery (91)

More Groups

People
  1. Nikolaus Schultz (80)
  2. Walid Chatila (30)
  3. David Solit (27)
  4. Michael Berger (27)
  5. Ritika Kundra (26)
  6. Jianjiong Gao (23)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (2)
  4. 2022 (12)
  5. 2021 (9)
  6. 2020 (19)

More Years

Publications
  1. Journal of Clinical Oncology (14)
  2. Nature Communications (12)
  3. Cancer Research (10)
  4. Clinical Cancer Research (9)
  5. Cancer Cell (5)
  6. Annals of Oncology (4)

More Publications

Publishers
  1. American Association for Cancer Research (22)
  2. Nature Publishing Group (20)
  3. American Society of Clinical Oncology (15)
  4. Cell Press (11)
  5. Oxford University Press (5)
  6. Wiley Blackwell (3)

More Publishers

Results (91)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The RNA-editing enzyme ADAR promotes lung adenocarcinoma migration and invasion by stabilizing FAK
    Journal Article

    Amin, E. M.; Liu, Y.; Deng, S.; Tan, K. S.; Chudgar, N.; Mayo, M. W.; Sanchez-Vega, F.; Adusumilli, P. S.; Schultz, N.; Jones, D. R.
    Science Signaling (2017)

    Fulltext@MSK | Save
  • Conditional selection of genomic alterations dictates cancer evolution and oncogenic dependencies
    Journal Article

    Mina, M.; Raynaud, F.; Tavernari, D.; Battistello, E.; Sungalee, S.; Saghafinia, S.; Laessle, T.; Sanchez-Vega, F.; Schultz, N.; Oricchio, E.; more...
    Cancer Cell (2017)

    Fulltext@MSK | Save
  • Transposon mutagenesis identifies chromatin modifiers cooperating with Ras in thyroid tumorigenesis and detects ATXN7 as a cancer gene
    Journal Article

    Montero-Conde, C.; Leandro-Garcia, L. J.; Chen, X.; Oler, G.; Ruiz-Llorente, S.; Ryder, M.; Landa, I.; Sanchez-Vega, F.; La, K.; Ghossein, R. A.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2017)

    Fulltext@MSK | Save
  • Integrated genomic characterization of oesophageal carcinoma
    Journal Article

    The Cancer Genome Atlas Research Network
    Nature (2017)

    Fulltext@MSK | Save
  • ARF confers a context-dependent response to chemotherapy in muscle-invasive bladder cancer
    Journal Article

    Owczarek, T. B.; Kobayashi, T.; Ramirez, R.; Rong, L.; Puzio-Kuter, A. M.; Iyer, G.; Teo, M. Y.; Sanchez-Vega, F.; Wang, J.; Schultz, N.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Emergence of RTK/RAS/PI3K pathway alterations in trastuzumab-refractory HER2-positive esophagogastric (EG) tumors
    Meeting Abstract

    Janjigian, Y. Y.; Sanchez-Vega, F.; Tuvy, Y.; Bouvier, N.; Riches, J. C.; Margolis, M.; Millang, B. M.; Scott, S. N.; Kundra, R.; Castel, P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Correlation between comprehensive molecular profiling and clinical outcomes in patients with colorectal liver metastases
    Meeting Abstract

    Connell, L. C.; Sanchez-Vega, F.; Boucher, T. M.; Yaeger, R. D.; Schultz, N.; Cercek, A.; Hechtman, J. F.; Kemeny, N. E.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Clinical next generation sequencing (NGS) of esophagogastric (EG) adenocarcinomas identifies distinct molecular signatures of response to HER2 inhibition, first-line 5FU/platinum and PD1/CTLA4 blockade
    Meeting Abstract

    Janjigian, Y. Y.; Sanchez-Vega, F.; Jonsson, P.; Tuvy, Y.; Bouvier, N.; Riches, J.; Kundra, R.; Ku, G.; Hechtman, J. F.; Kelsen, D.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Characterization of genomic alterations associated with metastatic tropism in a cohort of patients with renal cell carcinoma
    Meeting Abstract

    Becerra, M.; Sanchez-Vega, F.; Reznik, E.; Kashan, M.; Mendonca, S. J.; Manley, B.; Ghanaat, M.; Khan, N.; Coleman, J.; Russo, P.; more...
    BJU International (2016)

    Fulltext@MSK | Save
  • Recurrent, truncating Sox9 mutations are associated with sox9 overexpression, KRAS mutation, and TP53 wild type status in colorectal carcinoma
    Journal Article

    Javier, B. M.; Yaeger, R.; Wang, L.; Sanchez-Vega, F.; Zehir, A.; Middha, S.; Sadowska, J.; Vakiani, E.; Shia, J.; Klimstra, D.; more...
    Oncotarget (2016)

    Fulltext@MSK | Save